Literature DB >> 17766557

Best practices: surveillance and management of diabetes in a CMHC population.

Vinod H Srihari1, Cenk Tek, Lydia A Chwastiak, Scott W Woods, Jeanne L Steiner.   

Abstract

To improve detection and management of diabetes at a community mental health center, a cross-sectional study of the prevalence and management of type 2 diabetes mellitus was conducted among patients receiving maintenance antipsychotic medication (N=494). Diabetes was more than two-and-a-half times as prevalent among participants (17.4%) as in the general population. Fourteen percent of patients classified as diabetic had previously undiagnosed disease, compared with national sample rates of over 30%. Impaired fasting glucose was found for 26% of the sample. Glucose dysregulation was common. The known poor cardiovascular profile of persons with serious mental illness, reflected in the high rates of tobacco use and obesity in the sample, requires contextualizing efforts to screen and monitor for diabetes within overall efforts to monitor cardiovascular health.

Entities:  

Mesh:

Year:  2007        PMID: 17766557     DOI: 10.1176/ps.2007.58.9.1151

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  4 in total

1.  SCREENING FOR AND PREVALENCE OF HIV AND HEPATITIS C AMONG AN OUTPATIENT URBAN SAMPLE OF PEOPLE WITH SERIOUS MENTAL ILLNESS AND CO-OCCURRING SUBSTANCE ABUSE.

Authors:  Seth Himelhoch; Richard Goldberg; Christine Calmes; Deborah Medoff; Eric Slade; Lisa Dixon; Gerard Gallucci; Stanley Rosenberg
Journal:  J Community Psychol       Date:  2011-02-02

2.  Feasibility and effectiveness of an automated telehealth intervention to improve illness self-management in people with serious psychiatric and medical disorders.

Authors:  Sarah I Pratt; Stephen J Bartels; Kim T Mueser; John A Naslund; Rosemarie Wolfe; Heather S Pixley; Louis Josephson
Journal:  Psychiatr Rehabil J       Date:  2013-12

3.  Cardiovascular mortality in schizophrenia: defining a critical period for prevention.

Authors:  Vinod H Srihari; Vivek H Phutane; Banu Ozkan; Lydia Chwastiak; Joseph C Ratliff; Scott W Woods; Cenk Tek
Journal:  Schizophr Res       Date:  2013-02-17       Impact factor: 4.939

4.  Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial.

Authors:  Cenk Tek; Sinan Guloksuz; Vinod H Srihari; Erin L Reutenauer
Journal:  BMC Psychiatry       Date:  2013-06-27       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.